We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
+7.57%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$13.4B
AUM Growth
+$501M
Cap. Flow
-$544M
Cap. Flow %
-4.05%
Top 10 Hldgs %
33.24%
Holding
1,308
New
44
Increased
620
Reduced
282
Closed
30

Top Sells

Rank Stock Value
1
SPG icon
Simon Property Group
SPG
+$187M
2
WPC icon
W.P. Carey
WPC
+$162M
3
WELL icon
Welltower
WELL
+$126M
4
OHI icon
Omega Healthcare
OHI
+$110M
5
PLD icon
Prologis
PLD
+$84.3M

Sector Composition

Rank Sector Weight
1 Real Estate 60.72%
2 Technology 6.71%
3 Communication Services 3.62%
4 Consumer Discretionary 3.29%
5 Financials 3.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FULC icon
1176
Fulcrum Therapeutics
FULC
$248M
$1K ﹤0.01%
52
GERN icon
1177
Geron
GERN
$930M
$1K ﹤0.01%
684
LKFT
1178
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.84B
$1K ﹤0.01%
13
GOSS icon
1179
Gossamer Bio
GOSS
$100M
$1K ﹤0.01%
143
IDYA icon
1180
IDEAYA Biosciences
IDYA
$3.48B
$1K ﹤0.01%
55
IMUX icon
1181
Immunic
IMUX
$182M
$1K ﹤0.01%
4
INZY
1182
DELISTED
Inozyme Pharma
INZY
$1K ﹤0.01%
44
KALA icon
1183
KALA BIO
KALA
$12.3M
0
KALV
1184
DELISTED
KalVista Pharmaceuticals
KALV
$1K ﹤0.01%
46
+12
+35% +$315
KMDA icon
1185
Kamada
KMDA
$407M
$1K ﹤0.01%
84
KNSA icon
1186
Kiniksa Pharmaceuticals
KNSA
$6.11B
$1K ﹤0.01%
60
KPTI icon
1187
Karyopharm Therapeutics
KPTI
$161M
$1K ﹤0.01%
9
KRRO icon
1188
Korro Bio
KRRO
$151M
$1K ﹤0.01%
1
KZR
1189
DELISTED
Kezar Life Sciences
KZR
$1K ﹤0.01%
9
LEGN icon
1190
Legend Biotech
LEGN
$3.68B
$1K ﹤0.01%
40
MGTX icon
1191
MeiraGTx Holdings
MGTX
$1.09B
$1K ﹤0.01%
82
NGNE icon
1192
Neurogene
NGNE
$663M
$1K ﹤0.01%
4
NXTC icon
1193
NextCure
NXTC
$22.1M
$1K ﹤0.01%
4
PAHC icon
1194
Phibro Animal Health
PAHC
$1.48B
$1K ﹤0.01%
38
PBYI icon
1195
Puma Biotechnology
PBYI
$406M
$1K ﹤0.01%
87
RAPT
1196
DELISTED
RAPT Therapeutics
RAPT
$1K ﹤0.01%
6
RDHL
1197
Redhill Biopharma
RDHL
$4.44M
0
RIGL icon
1198
Rigel Pharmaceuticals
RIGL
$712M
$1K ﹤0.01%
37
RLMD icon
1199
Relmada Therapeutics
RLMD
$549M
$1K ﹤0.01%
31
RNAC icon
1200
Cartesian Therapeutics
RNAC
$225M
$1K ﹤0.01%
7

Similar funds

Daiwa Securities Group's Q1 2021 Portfolio in Review

As of Q1 2021, Daiwa Securities Group held 1,308 positions worth $13.4B, up 3.9% from $12.9B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Daiwa Securities Group withdrew a net $544M in Q1 2021, closing 30 positions and reducing 282 holdings. Its most notable exit was Global X Aging Population ETF, an estimated $13.9M position sold in full.

By sector, the portfolio is most concentrated in Real Estate at 61% of assets, up from 61% a quarter earlier, followed by Technology and Communication Services.

Against the trend, Daiwa Securities Group opened a new position in Global X Social Media ETF worth $73.4M.

  • Daiwa Securities Group's largest Q1 2021 buy was Global X Social Media ETF: 1,100,000 shares worth $73.4M.
  • Daiwa Securities Group added most to Digital Realty Trust in Q1 2021, an estimated $154M increase.
  • Daiwa Securities Group's biggest Q1 2021 reduction was Simon Property Group, cutting an estimated $187M.
  • Daiwa Securities Group fully exited Global X Aging Population ETF in Q1 2021, selling an estimated $13.9M.
  • Daiwa Securities Group's ten largest holdings make up 33% of its $13.4B portfolio in Q1 2021.
  • Daiwa Securities Group opened 44 new positions and closed 30 in Q1 2021.
  • Daiwa Securities Group's portfolio value rose 3.9% quarter-over-quarter to $13.4B.

Based on Daiwa Securities Group's 13F filing for Q1 2021, filed 3 May 2021.